title: Involvement of aldose reductase in the metabolism of atherogenic aldehydes.
abstract: Phospholipid peroxidation generates a variety of aldehydes, which includes free saturated and unsaturated aldehydes, and aldehydes that remain esterified to the phosphoglyceride backbone - the so-called 'core' aldehydes. However, little is known in regarding the vascular metabolism of these aldehydes. To identify biochemical pathways that metabolize free aldehydes, we examined the metabolism of 4-hydroxy-trans-2-nonenal in human aortic endothelial cells. Incubation of these cells with [3H]-HNE led to the generation of four main metabolites, i.e. glutathionyl HNE (GS-HNE), glutathionyl dihydroxynonene (GS-DHN), DHN and 4-hydroxynonanoic acid (HNA), which accounted for 5, 50, 6, and 23% of the total HNE metabolized. The conversion of GS-HNE to GS-DHN was inhibited by tolrestat, indicating that it is catalyzed by aldose reductase (AR). The AR was also found to be an efficient catalyst for the reduction of the core aldehyde - 1-palmitoyl-2- (5-oxovaleroyl)-sn-glycero-3-phosphorylcholine, which is generated in minimally modified low-density lipoprotein, and activates the endothelium to bind monocytes. As determined by electrospray mass spectrometry, reduction of POVPC (m/z=594) by AR led to the formation of 1-palmitoyl-2- (5)-hydrovaleryl-sn-glycero-3-phosphorylcholine (PHVPC; m/z=596). These observations suggest that due to its ability to catalyze the reduction of lipid-derived aldehydes AR may be involved in preventing inflammation and diminishing oxidative stress during the early phases of atherogenesis.
authors: Division of Cardiology, Department of Medicine, Jewish Cardiovascular Research Center, 500 South Floyd Street, University of Louisville, 40202, Louisville, KY, USA.
authors: S
authors: S
authors: Srivastava
authors: S Q
authors: SQ
authors: Liu
authors: D J
authors: DJ
authors: Conklin
authors: A
authors: A
authors: Zacarias
authors: S K
authors: SK
authors: Srivastava
authors: A
authors: A
authors: Bhatnagar
mesh_terms: D000449:Aldehyde Reductase / Q000378:metabolism*; D000447:Aldehydes / Q000378:metabolism*; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism*; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D010084:Oxidation-Reduction; D010742:Phospholipid Ethers / Q000378:metabolism
chemical_list: C400184:1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine; D000447:Aldehydes; D008077:Lipoproteins, LDL; D010742:Phospholipid Ethers; C099252:oxidized low density lipoprotein; D000449:Aldehyde Reductase; D005978:Glutathione; C027576:4-hydroxy-2-nonenal